Results 71 to 80 of about 4,732 (172)

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data

Vascular Health and Risk Management, 2007
Kirk A Bronander1, Michael J Bloch21Division of General Internal Medicine, 2Divisions of Cardiology and General Internal Medicine, Department of Medicine, University of Nevada School of Medicine, Reno, NV, USAAbstract: The endocannabinoid system (ECS) is
Kirk A Bronander, Michael J Bloch
doaj  

Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice

Brazilian Journal of Medical and Biological Research
Cannabinoid type 1 receptor (CB1R) inhibition tends to be one of the promising strategies for the treatment of obesity and other related metabolic disorders. Although CB1R inhibition may cause adverse psychiatric effects including depression and anxiety,
B. Chen, N. Hu
doaj   +1 more source

Involvement of CB1 cannabinoid receptors in methamphetamine-related decision-making and social behavior deficits. [PDF]

BMC Neurosci
Mousavi T, Hatami N, Niknamfar S, Naseri M, Rafaiee R, Tamijani SMS, Ranaiy MS, Ghazvini H.   +7 more
europepmc   +1 more source

Discrete Choice Experiment (DCE) as a Tool to Elicit Patient Preferences in a Complex Benefit-Risk Evaluation: A Case Study. [PDF]

Clin Drug Investig
E JY, Mt-Isa S, Hockley K, Zhu K, Tcherny-Lessenot S, Juhaeri J.   +5 more
europepmc   +1 more source

Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies. [PDF]

Mol Psychiatry
Costa GPA, Cerezo-Matias MA, Funaro MC, Bagdas D, Kaye A, Krystal J, Petrakis I, De Aquino JP.   +7 more
europepmc   +1 more source

Cannabinoid 1 receptor occupancy and neurovascular responses induced by agonist, antagonist/inverse-agonist and potential modulator in non-human primate brains: PET/fMRI study. [PDF]

J Cereb Blood Flow Metab
Yoo CH, Xu Y, Bagdasarian FA, Lin YS, Wang C, Wey HY.   +5 more
europepmc   +1 more source

Melatonin mitigates hormonal toxicity in cannabis-treated female Wistar rats: involvement of cannabinoid receptor. [PDF]

J Cannabis Res
Oluwasola A.
europepmc   +1 more source

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes. [PDF]

Alzheimers Dement
Vázquez-Oliver A, Pérez-García S, Romero-Pérez R, Pizarro N, Galarraga-Shinin D, Molina-Porcel L, de la Torre R, Maldonado R, Ozaita A.   +8 more
europepmc   +1 more source

Short Communication: The Peripheral Cannabinoid CB₁ Receptor Antagonist AM6545 Modifies Cardiovascular Effects of Endocannabinoids in DOCA-Salt Rats. [PDF]

Int J Mol Sci
Remiszewski P, Schlicker E, Grzęda E, Weresa J, Toczek M, Malinowska B.   +5 more
europepmc   +1 more source

Anti-inflammatory and analgesic potential of minor cannabinoids in vivo. [PDF]

J Cannabis Res
Vanegas SO, Gamage TF, Maturano J, Sarlah D, Kinsey SG.   +4 more
europepmc   +1 more source